Acute Myeloid Leukemia, in Relapse Clinical Trials in New York, New York
4 recruitingNew York, New York
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid LeukemiaMyeloid SarcomaAcute Myeloid Leukemia, in Relapse+7 more
Kura Oncology, Inc.420 enrolled44 locationsNCT05735184
Recruiting
Phase 1
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia, in RelapseRefractory Acute Myeloid Leukemia+1 more
Memorial Sloan Kettering Cancer Center15 enrolled7 locationsNCT06017258
Recruiting
Phase 1
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia, in Relapse
Bio-Path Holdings, Inc.48 enrolled4 locationsNCT05190471
Recruiting
Phase 1
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
Acute Myeloid Leukemia, in Relapse
Oryzon Genomics S.A.50 enrolled13 locationsNCT05546580